Business Context and Reporting Period
This Form 8-K is a current report filed by SELLAS Life Sciences Group, Inc. on July 2, 2019, covering the event date of July 1, 2019. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "SLS".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial statements.
Material Changes
Item 8.01 (Other Events) discloses that as of July 1, 2019, the company had 100,135,175 shares of common stock outstanding. No other material changes to financial position or operations are detailed in this document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total number of outstanding shares (100,135,175) as of July 1, 2019.
- Confirm the company's status as an emerging growth company.
- Review subsequent filings for financial performance data not included in this 8-K.